Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings

Biometrics

Volumn 54, Issue 4, 1998, Pages 1569-1578

  Baker, Stuart G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Noncompliance; Nonrandomized trials; Observational studies; Periodic screening evaluation; Poisson regression

Indexed keywords

DATA HANDLING; DISEASES; INFORMATION ANALYSIS;

ANALYSIS OF DATA; BREAST CANCER; BREAST CANCER SCREENING; CANCER MORTALITY; CONFIDENCE INTERVAL; NONCOMPLIANCE; NONRANDOMIZED TRIAL; OBSERVATIONAL STUDY; PERIODIC SCREENING EVALUATION; POISSON REGRESSION;

BIOPSY;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; DATA ANALYSIS; FOLLOW UP; MAMMOGRAPHY; ONSET AGE; PROBABILITY;

EID: 0032442348     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533681     Document Type: Article

References (9)

1. Baker, S. G. (1989). Innovations in screening: Evaluating periodic screening without using data from a control group. In Advances in Cancer Control, Volume VI, P. F. Engstrom, P. Anderson, and L. Mortenson (eds), 15-21. New York: Alan R. Liss.
2. Baker, S. G. (1997). Compliance, all-or-none. In The Encyclopedia of Statistical Science, Update Volume 1, S. Kotz, C. R. Read, and D. L. Banks (eds), 134-138. New York: Wiley and Sons.
3. Baker, S. G. and Chu, K. C. (1990). Evaluating screening for the early detection and treatment of cancer without using a randomized control group. Journal of the American Statistical Association 85, 321-327.
4. Brookmeyer, R., Day, N. E., and Moss, S. (1985). Case-control studies for estimation of the natural history of preclinical disease from screening data. Statistics in Medicine 5, 127-138.
5. Chu, K. C., Smart, C. R., and Tarone, R. E. (1988). Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan Clinical Trial. Journal of the National Cancer Institute 80, 1125-1132.
6. Day, N. E. and Walter, S. D. (1984). Simplified models for screening for chronic disease: Estimation procedures for mass screening programmes. Biometrics 40, 1-14.
7. Flanders, W. D. and Longini, I. M. (1990). Estimating benefits of screening from observational cohort studies. Statistics in Medicine 9, 969-980.
8. Flehinger, B. J. and Kimmel, M. (1987). The natural history of lung cancer in a periodically screened population. Biometrics 43, 127-144.
9. Fletcher, S. W., Black, W., Harris, R., Rimer, B. K., and Shapiro, S. (1993). Report of the International Workshop on Screening for Breast Cancer. Journal of the National Cancer Institute 85, 1644-1656.